📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing. (2023)

First Author: Achar J

Attributed to: Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1183/13993003.00969-2023

PubMed Identifier: 37945035

Publication URI: http://europepmc.org/abstract/MED/37945035

Type: Journal Article/Review

Volume: 62

Parent Publication: The European respiratory journal

Issue: 5

ISSN: 0903-1936